Avivagen Inc. announced a non-brokered private placement of 5,000,000 common shares at a price of CAD 0.2 per share for gross proceeds of up to CAD 1,000,000 on October 14, 2022. The company may pay finders' fees of 8% cash and 8% finders' warrants. All securities to be issued will be subject to a four-month and one day hold period.

The transaction is subject to acceptance of the TSX Venture Exchange.